Danaher (DHR)

[winston]

not vested

COVID-19 TESTS ARE IN HIGH DEMAND TODAY

Today's company profits during the fight against COVID-19...

The coronavirus sparked unprecedented and economically devastating shutdowns. Everyone is eager to open as soon as it's safe to do so. To make that determination, officials need lots of valid test results. And this company is a leading authorized supplier...

Danaher (DHR) is $125 billion manufacturing conglomerate specializing in health and science. One of Danaher's many subsidiaries, Cepheid, won government approval for a coronavirus test that provides a result in about 45 minutes.

Cepheid's test uses proprietary equipment that 5,000 U.S. hospitals already own. And as Forbes recently reported, Danaher's size and diversified holdings made it easy to produce lots of tests quickly.

As the chart shows, this company's success goes beyond COVID-19 testing... DHR shares have doubled over the past three years, and they recently hit a new all-time high.

Danaher's advanced products are always in demand, and its swift response to the coronavirus just gave it another tailwind...

Source: Daily Wealth